Exelixis Inc [EXEL] stock is trading at $34.12, up 2.77%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The EXEL shares have gain 22.43% over the last week, with a monthly amount glided 30.03%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Exelixis Inc [NASDAQ: EXEL] stock has seen the most recent analyst activity on October 16, 2024, when RBC Capital Mkts reiterated its Outperform rating and also boosted its price target to $34 from $30. Previously, UBS started tracking the stock with Neutral rating on September 19, 2024, and set its price target to $30. On April 11, 2024, downgrade downgraded it’s rating to Equal Weight but maintained its price target of $25 on the stock. BTIG Research started tracking the stock assigning a Buy rating and suggested a price target of $27 on December 19, 2023. Citigroup initiated its recommendation with a Buy and recommended $31 as its price target on December 15, 2023. H.C. Wainwright started tracking with a Buy rating for this stock on September 26, 2023, and assigned it a price target of $28. In a note dated August 22, 2023, Oppenheimer reiterated an Outperform rating on this stock and boosted its target price from $25 to $29.
Exelixis Inc [EXEL] stock has fluctuated between $19.20 and $33.60 over the past year. Currently, Wall Street analysts expect the stock to reach $30.5 within the next 12 months. Exelixis Inc [NASDAQ: EXEL] shares were valued at $34.12 at the most recent close of the market. An investor can expect a potential drop of -10.61% based on the average EXEL price forecast.
Analyzing the EXEL fundamentals
Exelixis Inc [NASDAQ:EXEL] reported sales of 2.08B for the trailing twelve months, which represents a growth of 14.33%. Gross Profit Margin for this corporation currently stands at 0.96% with Operating Profit Margin at 0.26%, Pretax Profit Margin comes in at 0.3%, and Net Profit Margin reading is 0.23%. To continue investigating profitability, this company’s Return on Assets is posted at 0.16, Equity is 0.21 and Total Capital is 0.2. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.08.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 33.49 points at the first support level, and at 32.86 for the second support level. However, for the 1st resistance point, the stock is sitting at 34.60, and for the 2nd resistance point, it is at 35.08.
Ratios To Look Out For
For context, Exelixis Inc’s Current Ratio is 3.93. As well, the Quick Ratio is 3.88, while the Cash Ratio is 0.66. Considering the valuation of this stock, the price to sales ratio is 4.81, the price to book ratio is 4.29 and price to earnings (TTM) ratio is 21.74.
Transactions by insiders
Recent insider trading involved Aftab Dana, CSO/EVP Disc & Trans Research, that happened on Oct 30 ’24 when 1162.0 shares were sold. Director, POSTE GEORGE completed a deal on Nov 01 ’24 to buy 30000.0 shares. Meanwhile, Officer JEFFREY J HESSEKIEL bought 25000.0 shares on Nov 01 ’24.
